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Objectives and Bock.gronnd. To awss the lon~term resu!ls 
of percutaneous aortic valvnloplasty and aortic valve replacement 
in e!derly persona. IWO sindtar nonrandandzed ~crics of patients 
275 years nld treated by O,W or the other methad be!vm 
Jant~ary 1986 and March 1989 in the same institutian were 
comaared. 
wi*h a meao ag of 78.4 + 2.4 years (range 75 tn 86) underwent 
aortic valve replacement with a hioprmthrsis lgraup 21. All aP 
them suffered from swwe catrified awtic stenosis. Clinical and 
twn&namie smtus were similar in both gmurr. The nrean 
folhw~p period was 2i.5 months (5 days to 60 months) in graup 
1 and 27.5 months I7 days to 61 months, in group 2. 
Results. Three patients (6.5%: in group I died within 5 days 
Percutaneous aortic valvuloplasty has been widely used in 
elderly patients since it was first inlrnduced by Cribier et al. 
(1;. However, its mid- and long-term results are being 
questioned because of the recurrence of symptoms linked to 
early restenosis in many palients. Conversely. aortic valve 
rcplacemcni. which has been commccly performed in et- 
derly patients during the past 10 years. ha? produced good 
resu!ls and relatively low mortality rates. Still. the respec- 
tive results ofthese fwo methods oftreatme:.t are not easy to 
compare because the patients frequently vary from one 
series to another. 
Hence. the purpose of this study is to compare the 
long-term results of percutaneous sonic wlvuluplasty and 
amtic valve replzcenm~! in two comparable s&es 12 pa- 
tients 275 years old treated during the same period in the 
same instbution. 
abler porcutanwas aortic valvuloplasty; 24 patients (52%) died 
during the Lltowup period, 16afwhamdied ofrecurrentrardiac 
fatlure. Of 16 patients ,35%, subseque”~ly operated on at an 
average af 15.8 months slier pprcutanw~s uwtie valvuloplarty, 2 
died at operalion. Only three group 1 pn(ients (6.5%) are still 
alive wilhuut suhseauutt aortic valve reolacemen~. h crow 2. 
two patients (8.7Bjdied postoperatively and threr !1<%) &I 
durinathe:otlow-up period. Attcther patienb(78k)srerrillalive 
and 1; New York. t&art Aswciato~ lunetionsl ckw I or II. 
The overa” rvrvival rate in group 1 (Ias 7.5% 3, t year. 47% at 2 
years and 23% at 5 yerrr. !?I wmup 2. the ~wrkn! rntr was BW 
at I aad 2 years attd 75% at 3 and 4 years. 
Conclusiow. The results of percvtaneaus aorttc vslvubptasty 
do not compare hvorrblr with thao ot suraw In elderly ptw,e. “. . . . 
and this treatment shwld not be recommended. 
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Methods 
Study group. Forty-six elderly patients who underwent 
percutaneous aortic valvuloplasty (group I) and 23 who had 
aortic valve replacement (group 2) between January 1986 
and March I989 in our instilution were enrolled in a retro- 
rpective analysis of lone_term results. 
The characteristics of the two groups are summarized in 
Table I. Twenty-lhree men and 23 women with an average 
age of 79.1 I 3.6 year> (range 75 to 90) underwent percuta- 
neous aonic valvuloplasty. Another 23 patients, 14 men and 
9 womeil with an average age of 78.4 2 2.4 years (range 75 
to 86). underwent amtic valve replacement. All of them bad 
severe calcified pw or oredominant aortic stenosis that was 
responsible for syncope ia : I patients (4 ia Sroup I and in 7 
in group 2) and for a@ on exertion in 22 patients (I I in 
group I and I1 in group ?I. Two patients in group I and five 
in group 1 had both symptwts. 
Fun&nal class was similar in both groups: 91% of 
patients in group t and 87% in group 2 were in New York 
Heart Association class 111 or IV. 
Seven patients in group I and four in group 2 had 
previously experienced symptoms of congestive cardiac 
failure. lschemic heart diseav was present al coronary 
aagiogaphy iu eight group 1 patients lone ot whom had 
undergone coronary angioplasty of the left antenor descend- 
ing artery 6 months before valvu!oplasryt. as well as in 6~ 
group 2 patients. 
Erhics. Beginning in 19%. we pave elderly patients auf- 
feting from symptomatic sonic sfenos~s informetion con- 
cerning percutaneous aottic valvutoptasty and aortic valve 
replacement. The choice between the two treatments was 
left to the patient. Since the beginrung of 1989. when it 
became apparent that the results of vhhplas~y were far 
from optimal, this procedure Las not been p&or&d m ow 
insiilotion. 
FwcuLlne,ms aorttc valwtaptPrty. In each case percuta- 
neous aortic valvuioplasty was conducted through the retro- 
grade femoral approach with use of the Cribier method (Il. 
The rioTtic valve area before and IO min after the proceaure 
was calculated according to the Gorhn formula with use of 
tk megn simultaneous left ventricular tu sonic gradient and 
cardiac outpu: determined by thermoditudon. Seteaiue CDT- 
onary angiog~aphy w% performed in att patients. *ortic 
valvuloplasty was carried out with the largest balloon cath- 
eter possib!e. A i%mm Schneider-Shiley balloon was used in 
14 cases. a Z&mm Mansfield balloon in 8. a 23.mm balloon in 
16. a 25-m” balloon in 4 and a trefoil Schneider-Shiley 
3 x I2 ballwn in 4 cases. 
Aortic valve replacemat. All patients were operated on 
by the same surgeon under moderate general hypothermia 
(29°C~ induced with cold crystallcid cardioplcgia with use of 
St-Thomas solution for myocardial protection. Rioprosthe- 
ses were inserted in all cases. a supraattnul~ Carpczier- 
Edwards prosthesis in 22 patients :;ld a 23 Med?onic iniact 
valve in one. Internal mammary artery-lefl anterior descend- 
ing coronary artery bypw grafting was also performed m 
!WO cases. 
Foitow-up dafs. Follow-up data were obtained either 
directly by examination or indirectly from the attending 
physician (general practitioner or cardiologist). End points 
at the lime of follorv-up included death, sonic valve replace- 
ment and clinical status. No fuflher percutaneous aortic 
valvulopias~ies were petimmed in this group. 
The mean fattow-up duratmn was 21.5 months 15 days to 
60rronth\l hrgroup ipalientsand27.5 monthst7days;o6t 
months) for group 2 patients. PO patients were lost dunng 
foilow-up. 
Statistical analvsis. Data are exoresxd as mea” value z 
SD. Statistical &lysis was peiormed with use of the 
Student-Fisher t test. Survival curves were established with 
the Kapk->ieier actuarial methad and compared with use 
of die iog rank test. 
Homodynamic and Doppler eehoeardiogrsphic data. 
Gro~~p I ipporieflrs undergoing percuraneous oonic vnlvrdn 
pinsly. Left ventricle to aorta maximal and mean gradients 
~wxe determined in all patients by Doppler echocardiog- 
rapby the day before aed ?g b after valvuloplasty. In all 
cases the same gradients were measured before and after the 
valvuloplasty during catheterization. 
Pretrealmtnt pressure gradients were very high (Table 2). 
The mean gradient was 65 + I6 mm Hg and the sonic valve 
xra 0.51 I 0.1s cm’ tnnxe O.tS 10 0.88) when determined 
by Doppler echocardiography; the mean gradient was 77 + 
21 mm Hg (range 0.27 to 0.80) when deter&ted hemody- 
namically. The Doppler-determined “tea” gradient de- 
creased from 65 to 41.4 mm Hg (p c o.CWll) and the 
hemodynamic mean gradient decreased from 77 to 
43.2 mm Hg (p < O.OCWl) after valvuloplasty. Aortic valve 
area estimated by Doppler echography increased fmm 0.51 
to 0.72 cm* on average sod that mrasured by catheterization 
increased from 0.47 to I).63 cm’ (p < O.OMWl) after the 
Procedure. 
I” the subgroup of 16 patients who underwent valve 
teplaccment after valvuloplasty (35% of group I), clinical 
stdtus, hemodyuamic maximal gradient 1109 t 24 mm Hg) 
and aortic valve area (0.13 + 0.24 cm2) before valvulopiasty 
were 801 significantI) d&rent from those of the total group 
::ables I and 2). 
The postvalvulopl~.sty data of the subgroup of 32 patients 
whoultimatelydiedcr’heatt failure or underwent subsequent 
valve replacement (18% of group I) were similar to those of 
the total group (Table 3). Memodynamic and Doppler 
maximal gradients were 57 * 22 and 60 + I5 mm HR. 
respectively, und valve are” was O.&l * 0.18 cm* and 0.75 + 
0.24 cm’. Left vetttticular function was not especially im- 
paired in these patients: left ventricular ejection fraction, 
available in 22 patients, averaged 0.58 + 0.10 (range 0.32 to 
0.71). 
Group 7 (patients sabmilted;o aunic vale ~qhcemenr). 
In these patients maximal and mean gradients were deter- 
mined with Doppler echocardiography or hemodynamic 
study. ot’ both. Aortic valve area was not calculated in all 
CBSES. On average, the maximal gradient was 107.9 r 
31 mm Hgandthe meangradient 67 + 23 mm Hg. At the first 
postoperative Dop+x echocardiographic examination, 
maximal and mean gradients of the bioprosihesis, available 
in 14 pa:ients, were 20 i- 9 mm Hp and 12 + 5.6 mm Hg, 
respectively. 
ltt~hospital mortality and morbidity. Group I. Three pa- 
tients (5.5%) died within 5 days after aottic valvuloplasty, 
,WO of !tem of a ma&e $‘r?ke. ‘;_ztomrlem erami&ofi 
showed that a tbrombus formatton on the a&c valve had 
caused the cerebral ischemic et&de in one of these ~a- 
tients. The third patient died sudbeoly of unknown causedon 
day 5. 
A left ventricular perforation occurred in two patients 
with immediate tamponade requiring emergency pericardio- 
centesis. Acute ischemia of a lower limb necessitated sugi- 
cal treatment in one patient. Another patient developed a 
pseudoaneurysm of the femoral artery that subseqoentiy 
required operation. In two cases transient complste atrio- 
ventricular block occurred during the procedure nccessitat- 
ine emereencv ventticular uacine (Table 4). The subseauent 
I . . _. 
cl&al course was uneventful in all these patients. 
Grouo 2. Two “atients (8.7%) died 7 ciavs “ostooera- 
tively during the in-hospital period: One died oia stroke: and 
the other of a right ventricular infarction. One patient had a 
tnnsisnr low cardiac output that required positive inotropic 
drug therapy. Hemorrhage leading to reoperution was ob- 
served in three patients whuse subsequent clinical course 
was favorable. Two patients had temporal disorientation that 
persisted for 4 weeks. Mediastinal apsis occurred in the 
patient who had undergone coronary artery bypass grafting 
of the left anterior descending artery in combination with 
aortic valve replacement. Paraprostl?etic leakage with mild 
aortic tnsufficiency (grade I + at Doppler study) was ob- 
served in three patients during the postopa?tive period. 
Long.tert” course. Group I Fig. I). Twenty-four (52%) 
of the 43 patients discharged fmm the hospital died during 
the follow-up peri,od between I month and 4 years (average 
15.9 months) after valvuIo~last~. Of these. 16 patients (37%) 
died of rec&nt cardiac’failire, I of sudden death, 2 of 
myocardial infarction, I of caocer and pulmonay embolism 
and 4 of unknown cause. 
Sixteen patients (35%) were operated on from 2 weeks to 
45 months (average IS 8 months) r&r valvsloplasty. All 
received a bioprosthesis. Two patients died during the 
postoperative period: the other 13 are still aiive and doing 
well (9 in functional &.B I and 4 in chss II). 
year5 after valve replacement. All other patients 178%) are 
dsix well: I4 are in lunctio~!al clars I and 4 in class I! and 
none have required an addiriona! operation. 
Long-term suniva!. Survival rate was estimated wtth use 
of tbe actuarial method (Fig. 3). The overall survival rate for 
patients who underwent va!vu!op!astty MS 75% at I year, 
47% at 2 year5 and 33% at 5 years. In the subgroup of 
patients who did not undergo subsequent aottic v& re. 
plwement. the survival rate was only 65% at I year. 26% at 
2 fears. 19% at 3 years ad 8% at 4 and 5 years. 
Conversely. in patients operated on without prior valvu- 
loplasty. the sur+a! rate was 83% at I and : years and 75% 
at 3 and 4 years. These data coincide wth the survival 
curw\ of ihc iziura: iwopala!ion in the same age groupa. 
The log rank test shows that survival rates differed 
s.:nificantly between patients in groups I and 2. Tbe di5er. 
exe is even more significant when considering patients 
undergang valvuloplasty without subsequent awtic valve 
repiacement, patients undelguing va!vu!op!asty with subs+ 
quest aortic v&e replacement and patients operated on 
Bigare 1. Long-term course of patwntr who undewcnt percutane- 
0”s aortic valvuloplasty !gmep I). 
without prior va!vuloplasty (Fig. 3). 
Only three W’G of the nonsurgically trcatcd group I Dismssion 
patients, aged 71.79 and 83 years, respectively. at the time Limitaiiottsoft!teshtdy. This retrospective anaiysiscotn- 
of percutaneous aortic valvuloplasty, are still alive 29 to 46 pared the results of percutaneous a xtic va!vu!op!asty with 
months after the procedure; all three are in functional class those of aontc valve replacement. The main limitation of the 
Il. study is tbr absence of randomization. in fact. in this series 
Group 2 (Fig. 2). Three (13%) of the 21 patients dis- of69 consecutive patients 575 years old the choice between 
charged from the hospital died during the follow-up period. the two treatments was left to the patient. This explains why 
One died of endocarditis at 6 months. one of mywardial most gtieots chase valvuloplasty. Althaw& th-y were not 
infnrction at I year and one of an unexplained cause at 2.5 randomized. the two patient groups are quite similar ti to 
see. functional class. sonic wessure xradient and left vew 
t&lx function (Tables I ad 2). _ 
Rgu~h 2. Long-term cowse of patients who undewem some valve 
replacement @cap 2). NYHA = New York Heart Association. 
Immediate mmta!ity nod web!@. nrce (6.5%) of 46 
patients in group I and 2 (8.7%) of 23 in group 2 died during 
the in-hospital pried. Other studies have presented an initial 
morality rate usually a little higher after aortic valve re- 
placement han after penxtaneous amtic va!vu!op!asty. In 
other series (2-4) cwxming percutaneous aortic va!vu!c- 
plasry in elderly patients, a in-hospital mxta!ity tale of 
6.5% to 7.5% was reported. Feriprw:dural morbidity IS hii 
dtei percutaneous &tic valvulopla5ty not only because of 
the poor condition of the patients but also becwse of the 
technique itself. In an extensive. recently repotled North 
American series (5) the ova-all cJmplicati?n rate for the 
procedure. 20.5%; higher than in ours&es. included ~ascu- 
lar injury in !I%, left ventricular perforation resulting in 
tampmade in 1.8%. cerebral emtmlic events in 2.2%, ttox- 
fatal arrhythmia in 0.8% and messIve aortic regurgitation. 
which did not ofcur in our series, in 1%. 
Others (6.7) have reported an in-hospital death rate after 
aottic valve replacement similar to ours. Cull&d et a!. (8) 
reported an e&oumgingly low mortality rate of 5.7% in 
patients a80 years old undergoing sonic vi Ive replacement 
alone. Aortic valve replacement was found ‘o be the opera- 
tion associated with the lowest operative mortality rate 
(6. I%) in patients >70 years old (91. Is all of these studies 
the combination of aonic valve reolacement and coronary 
artery bypass grafting increases ihe immediate mortalit; 
rate: 19.4% in octogenarians in the series of Culliford et al. 
(8). In these elder& patients mortality and morbidity are 
frequently stroke related (6,7.10). 
Hemodynamic wults. In our study the results obtained 
bg percutaneous aortic valvuloplasty proved unsntisfactoly. 
Only a few invrstigators have obtained better tmmcdiatc 
results with this technique. In the extenwe series of Saliao 
et al. (1 I) sonic valve arca was no.90 cmz on average at the 
end of tbc procedure. The initial sonic valve arca in thar 
series averaged 0.60 t 0.20 cmz, indicating that the stenows 
isv&!vcd were iess severe in that series than in ours. Letac et 
al. (3) found an increase of aortic valve area from 0.48 + 
0.16 cm’ to 0.91 ? 0.35 cm’ in oc!ogenarians, with an 
incrwsc ofaur:ic valve area >I cm* in one third of cases. 
Tbw d:screpanGes are dBtcub 10 explain. A technically 
inadequate prumdure cannot accoun’ for rhese diffcrcnces. 
In our in&ion each YBII dtoplasly was carried out by the 
same skilled senior vhvsiciin with a total exoerience of z 100 
percutaneous ao& &~uloplas~ies. The &mx types and 
siccs of balloon catheters and the same retrograde technique 
of valvuloplasty as those described by Crib&e! a!. (i) we:e 
used. Large-sized ba!!asns were employed whenever possi- 
bie; 23.mm and 25.mm balloons were used for 43% of the 
procedures. 
In fact, our immediate results are similar to those of most 
investigators 02-15) u&o have performed percutaneous 
axtic valvulordast~ in cnmoarahle series. that is. in elderlv 
patients with ;ery.reduced’aotxic valve &a. In the recent 
report of the Mansfield Scientific Aortic VBIvuio&w~ Rce- 
i&y t-C), the results of valvutoplasty in patients i9 ye&s aid 
were not significantly different frum ours: sonic valve area 
in their study increased from 0.51 to 0.82 cn?versus 0.53 to 
0.74 cm2 at Doppler study in our experience. Thus, in nvxt 
cases the only beneficial e&t of percutaneous aoriic val- 
vuloplasty was an evolution in aortic stenosis from critical to 
severe. 
Moreover. early or midterm restenosis is common, OE- 
curing within a f&v days or weeks after the procedure. as 
demonstrated by hemodynamic (I 1.16-18) or Dosuter fl9j 
assesvnent or a combined Doppler echocardiugr&hic and 
henwdynamic method (20). A restenosis rate 3s high as i6% 
di b months has been reported (161. II must be emphasized 
that :he flirka! course does not strictly parallel the objective 
rcsuIt5 of valvr1lnplasty (18,20!. 
Long-term cavrse. In our series the tori@@@ mu results of 
percutaneous aortic valvulaplasty were very unsatisfx.:a-y. 
only 3 of 46 patients rcrvivcd -without subsequent aortic 
,vaive replacement ~2.5 years aiter the procedure. In this 
group Ihe prokbili!l of survival does not exceed 8% at 4 
wrs. The course of oatienls who underwent valvulo~lastv 
&d subsequently unherwm aortic valve replace&t & 
much more favorable, wirh 13 (87%) of 15 uatients survivina 
in good clinical status, as has also been reported by others 
(21). 
Few reports have been published cmxeming the long. 
term resa!:s of percutaneous aoriic valvuloplasty (22.23). 
Legrand et al. (IS) found a survival rate of 72% and 62%. 
respectively. at I and 2 years (7.5% and 47% respectively, in 
our series). They also found that 68% and 4l%, respectively, 
of swviv~rs showed improvement or could be managed 
medically at I and 2 years (65% and 26% in our exserience). 
In 50 elderly p&en& suffering from severe an& stenosis 
and treated medically, r)‘K.eefe et al. (24) found a I-. 2. and 
:.year survival rate of 57%. 37% and 25%. respectively. All 
these data suggest that percutaneous aortic valvuloplasty 
provides B short-term benefit within the year after dilation 
but no beneficial e&t after I gear. 
One important question raised by our study is why 1” 
palients who I;ndcrw:o: “alvuloplasty did not unde: cr, sub. 
sequent awtic valve replacement and dwd of recurrent 
cardiac failure. In fact. most of these elderly palicntr. who 
had initially selected pcrcutancwr aurtic “al”u!oplar~y. 
once more chore to rrfuss swgery. Fwt:>ermore. Fame 
patients simply did not consult their physician. as is common 
in rural areas. and we were informed of their death after- 
ward. 
The long-term results of surg~cid treatment are much 
more favorable. The survival rate of pa&lb dischareccd 
from the hospital did not differ signiii&y irom the survkal 
curves of Lhe generai population in the rame age groups. ?he 
only valve-related lethal complication that occurred during 
the follow-rp period was a case of infective endacardiris. 
Xotdetha~ complicalions we; represented by three case, of 
paravalvular leak. All patients received a bioprostbesis and 
none received andcoagu!mt therapy. Moreover. all (hi: 
surviving patients experienced dramatic improvement I” 
their clinical s~+tus and thrk quality of life remains very 
satisfactory; all are in func:iond class I or II. Similar results 
hnve bcea rezoned bv others M.8.10.25.261. 
Conclusions. II is.obvious from our findings that the 
results ofpercutaneous aortic valvuloplasty do not favorably 
compare with those of surgery in elderly parients suffering 
from critical aortic stenosis. In our opinion. ptxcutaneous 
aortic valvuloplasty should not be pafwmed or performed 
in un:y a few cases as a preparation for surgery. 
